NAINR. 2013;13(4):189-195.

The chemotherapy regimen itself is agnostic to molecular subtypes of gastric cancer. The authors are to be congratulated for PRODIGE 51-FFCD-GASTFOX, which supports docetaxel as part of the preferred ...

Optune Lua received a CE Mark for treating metastatic NSCLC, used with immune checkpoint inhibitors or docetaxel after progression on a platinum-based regimen. The phase 3 LUNAR trial showed ...

University of Kentucky, Lexington, KY.

We recommend using an algorithm, like the one presented here, to guide actions once extravasation occurs. Using non-pharmacologic approaches to treat the injury is a first step in the process of ...

University of Illinois at Chicago, Chicago, IL.

BCG might be superior to sequential intravesical gemcitabine-docetaxel for reducing the risk of recurrence in patients with high-grade intermediate-risk NMIBC. Given the recent global shortage of ...

Novocure has obtained CE Mark approval for its Optune Lua device to treat adults with metastatic non-small cell lung cancer (NSCLC) simultaneously with immune checkpoint inhibitors or docetaxel. This ...

Introduction Umbilical venous catheter (UVC) related extravasation is an under recognised yet potentially catastrophic complication. 1 A series of near fatal UVC extravasations prompted a ...